Medicare Enrolled
Dr. Venkatesh Janakiraman, M.D.
Neurology · Bakersfield, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Janakiraman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Janakiraman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Janakiraman
Dr. Venkatesh Janakiraman is a neurology specialist in Bakersfield, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Janakiraman performed 711 Medicare services across 540 unique beneficiaries.
Between the years covered by Open Payments, Dr. Janakiraman received a total of $13,553 from 68 pharmaceutical and/or device companies across 624 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Janakiraman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 38% volume in CA
$13,553 industry payments
Medicare Practice Summary
Medicare Utilization ↗711
Medicare services
Top 38% in CA for neurology
540
Unique beneficiaries
$155
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~55 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
146 | $136 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
114 | $93 | $200 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
66 | $79 | $200 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
57 | $206 | $550 |
| New patient office visit, complex (60-74 min) | 57 | $165 | $375 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
56 | $372 | $700 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
55 | $237 | $650 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
28 | $315 | $650 |
| Electromyography of 2 extremities A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function. |
28 | $134 | $360 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
28 | $104 | $200 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
26 | $101 | $250 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
26 | $27 | $90 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
24 | $28 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,553
Total received (2018-2024)
Avg $1,936/year across 7 years
Top 20% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
624
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,459 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$94 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,705
2023
$1,356
2022
$2,356
2021
$2,030
2020
$1,882
2019
$1,706
2018
$2,518
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$251
UCB, Inc.
$209
Merz Pharmaceuticals, LLC
$190
ARGENX US, INC.
$167
Neurelis, Inc.
$158
Amgen Inc.
$135
Eisai Inc.
$99
ACADIA Pharmaceuticals Inc
$96
CATALYST PHARMACEUTICALS, INC.
$68
Novartis Pharmaceuticals Corporation
$64
Lilly USA, LLC
$57
PFIZER INC.
$51
Lundbeck LLC
$41
AstraZeneca Pharmaceuticals LP
$29
Teva Pharmaceuticals USA, Inc.
$25
BANNER LIFE SCIENCES, LLC
$24
Kyowa Kirin, Inc.
$22
Alexion Pharmaceuticals, Inc.
$18
Top 3 companies account for 38.1% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$1,931
Novartis Pharmaceuticals Corporation
$897
EMD Serono, Inc.
$846
UCB, Inc.
$751
ABBVIE INC.
$706
Biogen, Inc.
$645
Merz Pharmaceuticals, LLC
$589
Supernus Pharmaceuticals, Inc.
$578
Neurelis, Inc.
$546
Amgen Inc.
$392
Sunovion Pharmaceuticals Inc.
$369
Alexion Pharmaceuticals, Inc.
$365
ACADIA Pharmaceuticals Inc
$292
SK Life Science, Inc.
$281
Eisai Inc.
$253
Adamas Pharmaceuticals, Inc.
$249
Neurocrine Biosciences, Inc.
$246
Teva Pharmaceuticals USA, Inc.
$232
ARGENX US, INC.
$213
Kyowa Kirin, Inc.
$202
PFIZER INC.
$189
Lilly USA, LLC
$186
Abbott Laboratories
$179
Allergan, Inc.
$168
AstraZeneca Pharmaceuticals LP
$146
EISAI INC.
$137
Ipsen Biopharmaceuticals, Inc
$133
Biohaven Pharmaceutical Holding Company Ltd.
$132
Akcea Therapeutics, Inc.
$120
Greenwich Biosciences, Inc.
$96
AbbVie Inc.
$88
Biohaven Pharmaceuticals, Inc.
$88
Merz North America, Inc.
$77
Horizon Therapeutics plc
$71
CATALYST PHARMACEUTICALS, INC.
$68
Avanir Pharmaceuticals, Inc.
$68
JAZZ PHARMACEUTICALS INC.
$66
Lundbeck LLC
$65
Amylyx Pharmaceuticals, Inc.
$64
Ceribell, Inc.
$60
US WorldMeds, LLC
$57
Mallinckrodt Enterprises LLC
$54
Sumitomo Pharma America, Inc.
$53
Allergan Inc.
$51
MITSUBISHI TANABE PHARMA AMERICA, INC.
$43
Alnylam Pharmaceuticals Inc.
$41
Celgene Corporation
$38
Saol Therapeutics Inc.
$35
GRT US Holding, Inc.
$32
Otsuka America Pharmaceutical, Inc.
$26
AQUESTIVE THERAPEUTICS, INC.
$26
Impax Laboratories, Inc.
$25
Mallinckrodt Hospital Products Inc.
$24
BANNER LIFE SCIENCES, LLC
$24
Takeda Pharmaceuticals U.S.A., Inc.
$22
Mitsubishi Tanabe Pharma America, Inc.
$21
Boston Scientific Corporation
$21
MERZ NORTH AMERICA, INC.
$20
Janssen Pharmaceuticals, Inc
$18
GENZYME CORPORATION
$17
Acorda Therapeutics, Inc
$17
Exeltis, USA Inc.
$17
Medtronic USA, Inc.
$16
ANI Pharmaceuticals, Inc.
$16
Upsher-Smith Laboratories LLC
$16
Retrophin, Inc.
$14
Zogenix Inc.
$13
Strongbridge US INC.
$11
Top 3 companies account for 27.1% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRILINTA · Briviact · Ceribell Rapid Response EEG · DAYBUE · DUOPA · DYSPORT · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · ONPATTRO · OXTELLAR XR · Ongentys · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RADICAVA · RELYVRIO · REXULTI · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SUPERION · SYMPAZAN · Soliris · TEGSEDI · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · XCOPRI · XEOMIN · Xeomin · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
18
Per 100K population
2.0
County median income
$67,660
Nearest hospital
BAKERSFIELD BEHAVIORAL HEALTHCARE HOSPITAL, LLC
4.6 mi
4.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Janakiraman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Janakiraman experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Janakiraman performed 146 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Janakiraman receive payments from pharmaceutical companies?
Yes. Dr. Janakiraman received a total of $13,553 from 68 companies across 624 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Janakiraman's costs compare to other neurologists in Bakersfield?
Dr. Janakiraman's average Medicare payment per service is $155. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Janakiraman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Bakersfield
Browse neurologists in Bakersfield ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology